beth Seidenberg

Mary Meeker, author of the Internet Trends Report, is leaving Kleiner Perkins

Mary Meeker is leaving Kleiner Perkins to build a new fund and she's taking the firm's growth team with her, as first reported by Recode. Meeker, widely known for her annual Internet Trends Report, jo

Longtime Kleiner Perkins investor Beth Seidenberg has raised $320M for her own fund

Beth Seidenberg, a general partner at Kleiner Perkins since 2005, has taken the wraps off her new fund, Westlake Village BioPartners. The Los Angeles-based firm has raised $320 million to incubate and

Beth Seidenberg of Kleiner Perkins is starting her own fund

Beth Seidenberg joined Kleiner Perkins 13 years ago to focus on life sciences for the storied venture firm. Now, according to a Recode report, she’s heading off to start her own life sciences ve

Healthcare Is The Last Industry To Be Disrupted, Says KPCB’s Beth Seidenberg

Tech has changed almost every aspect of our lives, from shopping to transportation. But despite the enormous amount of money Americans spend on healthcare, many treatments are decades old. In an onsta

Meet The Disrupt SF 2015 Speakers And Judges

Disrupt SF is just a few weeks away, and we have some of the most iconic entrepreneurs and thought leaders in the tech industry lined up to speak throughout the three-day-long conference.

M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF

Beth Seidenberg is a licensed physician immunologist who helped bring drugs like the asthma drug Singulair and the pain medication Vioxx to market before turning to venture capitalism. As a partner at